| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | 28-Dec-08 | | Total Revenue | 77,785 | 87,907 | 97,546 | 99,807 | | Cost of Revenue | 64,958 | 68,600 | 78,315 | 82,162 | | | Gross Profit | 12,827 | 19,307 | 19,231 | 17,645 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 7,236 | 9,515 | 8,115 | 8,664 | | Non Recurring | (514) | 1,075 | 160 | 91,023 | | Others | 4,130 | 4,150 | 4,095 | 4,506 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 955 | 4,567 | 6,861 | (86,548) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,080) | 267 | 152 | 105 | | Earnings Before Interest And Taxes | (5,165) | 4,834 | 7,013 | (86,443) | | Interest Expense | (4,134) | 1,849 | 2,285 | 3,433 | | Income Before Tax | (1,031) | 2,985 | 4,728 | (89,876) | | Income Tax Expense | (113) | 368 | 948 | (29,814) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (918) | 2,617 | 3,780 | (60,062) | | | Non-recurring Events | | Discontinued Operations | (35) | (293) | (35) | (589) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (953) | 2,324 | 3,745 | (60,651) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($953) | $2,324 | $3,745 | ($60,651) |
|
0.83% Nasdaq 
Income Statement
